Home - Products - Others - Other Targets - Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside

Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside

CAS No. 142451-65-8

Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside( —— )

Catalog No. M23575 CAS No. 142451-65-8

Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside is a natural peoduct isolated from Arabian jasmine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 855 In Stock
10MG 1161 In Stock
25MG 1701 In Stock
50MG 2322 In Stock
100MG 3132 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside is a natural peoduct isolated from Arabian jasmine.
  • Description
    Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside is a natural peoduct isolated from Arabian jasmine
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    142451-65-8
  • Formula Weight
    594.52
  • Molecular Formula
    C27H30O15
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DL -34-Dihydroxymand...

    34-Dihydroxymandelic acid is a minor metabolite of norepinephrine in humans. Patients with neuroblastoma experience elevated levels of 34-Dihydroxymandelic acid.

  • Di-O-methylbergenin

    Di-O-methylbergenin is a natural product for research related to life sciences.

  • Thymidylate Kinase I...

    YMU1 is a human thymidylate kinase (hTMPK) inhibitor. YMU1 stabilizes the conformation of ligand-induced degradation (LID) region of hTMPK and blocks the catalytic site or ATP-binding site.